FranceLEVO - Zimino Registry (FZR)

NCT04252404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-07-21

No results posted yet for this study

Summary

The French National Authority for Health (Haute Autorité de santé) requested a registry study to obtain post-market surveillance data to describe baseline clinical profiles, management and outcome of patients treated with Zimino®. This study is designed to provide real-life data on the use, safety and clinical outcomes of Zimino® in routine clinical practice in France.

Conditions

  • Acute Heart Failure

Sponsors & Collaborators

  • Arcothova

    lead OTHER

Principal Investigators

  • Bernard CHOLLEY, MD, PhD · Arcothova

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2021-01-27
Completion
2021-05-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04252404 on ClinicalTrials.gov